Adial ceo william stilley invited to participate in maxim group's virtual panel series conference: “disruptors in the mental health space”

Charlottesville, va., sept. 15, 2021 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that william stilley, chief executive officer of adial pharmaceuticals, has been invited to participate in maxim group's virtual panel series conference: "disruptors in the mental health space," which will be taking place on wednesday, september 22, 2021 from 9:00am-3:00pm et.
ADIL Ratings Summary
ADIL Quant Ranking